| Value | ₹0.17 Cr |
|---|
NSE filing, NSE: BEACON. Summary written from the filing by ALFA Finder's alert engine.
Beacon Trusteeship Ltd: key numbers
- Share price
- ₹85.00
- Market cap
- ₹153.8 Cr
- Revenue (annual)
- ₹34.16 Cr
- Net profit (annual)
- ₹6.98 Cr
- P/E (TTM)
- 22.0×Sector 43.1×
- Promoter holding
- 46.08%
- FII holding
- 2.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beacon Trusteeship Ltd
All →Beacon Trusteeship Employee Stock Options
Beacon Trusteeship Limited has granted 50,500 Employee Stock Options to eligible employees under the BTL ESOP Plan 2025.
Beacon Trusteeship Other Announcement
Beacon Trusteeship Limited informed the exchange that Corporate Governance provisions are not applicable to the company for the quarter ended September 30, 2026.
Beacon Trusteeship Regulatory Approval
Beacon Trusteeship's subsidiary, Beacon Investor Holdings, received SEBI approval to operate as a trading member on the Metropolitan Stock Exchange (MSEIL).
Beacon Trusteeship Other Announcement
Beacon Trusteeship Limited's board approved amending its Memorandum of Association to expand its business scope. This enables potential future entry into new financial services segments.
Beacon Trusteeship Merger & Restructuring Worth ₹0.25 Cr
Beacon Trusteeship Limited is incorporating a Wholly Owned Subsidiary in Dubai for financial services. The investment for this expansion is approximately INR 25 Lakhs (0.25 Crore).
- Value
- ₹0.25 Cr
Beacon Trusteeship Board Meeting Outcome
Beacon Trusteeship's board approved incorporating a wholly-owned subsidiary in Dubai and altering its Memorandum of Association's object clause to diversify business activities.
- Value
- ₹0.25 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date